Most not too long ago, it's been recognized that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in similar spots as classical opioid receptors, it binds into a big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts to be a scavenger and will not act